Delivery Order SPE2DB20D7061-SPE2DB25FSPS2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) valued at $5,783.47, with delivery completion by September 10, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The prime contractor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $6,805.45 to AmerisourceBergen Drug Corp for Concerta ER 36 mg tablets (100-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order valued at $7,185.49 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $5,573.88. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery order is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $45,836.39 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100 count) with a ceiling value of $5,428.87. This firm fixed price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Concerta ER 36 mg tablets (100 count) with a contract value of $10,721.06. This non-competitive delivery order represents a firm fixed price transaction with an ultimate completion date of August 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $31,897.20 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order represents a single-line item pharmaceutical procurement supporting federal medical supply needs. The award was issued without a set-aside designation and will be performed at the contractor's facility...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Concerta ER 27 mg tablets (100 count) with a ceiling value of $23,371.40. This firm fixed price delivery order, which concludes on September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The award was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $3,689.20 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPS2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $26,934.45 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on September 11, 2025, with completion targeted for September 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. This specific delivery order for methylphenidate extended-release tablets supports the Defense Health Agency and other government healthcare systems requiring controlled pharmaceutical products through the flexible and competitive contracting framework established under the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.9k | 9/11/25 |